Randomized Study of Acetylcysteine in Patients With Acute Liver Failure Not Caused by Acetaminophen
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
This PHASE3 trial investigates Acute Liver Failure and is currently completed. National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) leads this study, which shows 8 recorded versions since 1998 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Change History
8 versions recorded-
Sep 2025 — Present [monthly]
Completed PHASE3
-
Sep 2024 — Sep 2025 [monthly]
Completed PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE3
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE3
-
Jun 2018 — Jan 2021 [monthly]
Completed PHASE3
▶ Show 3 earlier versions
-
Oct 2017 — Jun 2018 [monthly]
Completed PHASE3
-
Feb 2017 — Oct 2017 [monthly]
Completed PHASE3
-
Jan 2017 — Feb 2017 [monthly]
Completed PHASE3
First recorded
Jun 1998
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- University of Texas Southwestern Medical Center
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Ann Arbor, United States, Birmingham, United States, Boston, United States, Charleston, United States, Chicago, United States, Dallas, United States, Durham, United States, Jacksonville, United States, Los Angeles, United States, New York, United States and 12 more location s